Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Preferred Stock Liabilities (2018 - 2020)

Outset Medical has reported Preferred Stock Liabilities over the past 3 years, most recently at $452.3 million for Q2 2020.

  • Quarterly Preferred Stock Liabilities changed N/A to $452.3 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $452.3 million through Jun 2020, changed N/A year-over-year, with the annual reading at $409.4 million for FY2019, 4.37% up from the prior year.
  • Preferred Stock Liabilities was $452.3 million for Q2 2020 at Outset Medical, roughly flat from $452.3 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $452.3 million in Q1 2020 and troughed at $392.3 million in Q4 2018.
  • The 3-year median for Preferred Stock Liabilities is $409.4 million (2019), against an average of $423.1 million.
  • The largest YoY upside for Preferred Stock Liabilities was 4.37% in 2019 against a maximum downside of 4.37% in 2019.
  • A 3-year view of Preferred Stock Liabilities shows it stood at $392.3 million in 2018, then grew by 4.37% to $409.4 million in 2019, then rose by 10.46% to $452.3 million in 2020.
  • Per Business Quant, the three most recent readings for OM's Preferred Stock Liabilities are $452.3 million (Q2 2020), $452.3 million (Q1 2020), and $409.4 million (Q4 2019).